Responses
Immune cell therapies and immune cell engineering
Original research
Blockade of AIM2 inflammasome or α1-AR ameliorates IL-1β release and macrophage-mediated immunosuppression induced by CAR-T treatment
Compose a Response to This Article
Other responses
No responses have been published for this article.